← FDA Drug Approvals (Drugs@FDA)

RAPIVAB

NDA · New Drug Application · Sponsor: BIOCRYST · Approved 2014-12-19

Drug application

FDA Application #

NDA206426

Application type

New Drug Application

Brand name

RAPIVAB

Generic name

PERAMIVIR

Active ingredients

PERAMIVIR

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BIOCRYST

Manufacturer

BioCryst Pharmaceuticals, Inc.

First approval

2014-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown